Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 62,950 | 54,386 | 36,934 | 53,848 | 39,818 |
| Operating Income | -62,950 | -54,386 | -36,934 | -53,848 | -39,818 |
| Other Income | 3,433 | 1,713 | 1,623 | 1,893 | 48 |
| Pre-tax Income | -59,517 | -52,673 | -35,311 | -51,955 | -39,770 |
| Net Income Continuous | -59,517 | -52,673 | -35,311 | -51,955 | -39,770 |
| Net Income | $-59,517 | $-52,673 | $-35,311 | $-51,955 | $-39,770 |
| EPS Basic Total Ops | -4.40 | -15.28 | -124.41 | -21.20 | -21.90 |
| EPS Basic Continuous Ops | -4.40 | -15.28 | -124.41 | -21.21 | -21.92 |
| EPS Diluted Total Ops | -4.40 | -15.28 | -124.41 | -21.20 | -21.90 |
| EPS Diluted Continuous Ops | -4.40 | -15.28 | -124.41 | -21.21 | -21.92 |
| EPS Diluted Before Non-Recurring Items | -4.40 | -15.28 | -25.20 | -21.20 | -21.90 |
| EBITDA(a) | $-62,120 | $-53,582 | $-36,374 | $-54,560 | $-39,566 |